MeSH term
Frequency | Condition_Probility | Adolescent | 3 | 0.0 |
Adult | 9 | 0.0 |
Aged | 8 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Female | 25 | 0.0 |
Humans | 59 | 0.0 |
Male | 20 | 0.0 |
Middle Aged | 10 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Animals | 9 | 0.0 |
Cattle | 2 | 0.0 |
Mice | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Alleles | 15 | 0.0 |
Blood Proteins/*genetics | 22 | 13.0 |
Codon | 2 | 0.0 |
Comparative Study | 9 | 0.0 |
Models, Genetic | 3 | 0.0 |
Phenotype | 20 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Polymorphism, Genetic | 10 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
alpha-Fetoproteins/*genetics | 2 | 3.0 |
Base Sequence | 5 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Glycoproteins/genetics | 2 | 2.0 |
Rats | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Ecuador | 2 | 18.0 |
Ethnic Groups/genetics | 2 | 1.0 |
*Gene Frequency | 5 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Acute-Phase Proteins/*metabolism | 2 | 3.0 |
Body Weight | 2 | 0.0 |
Bone Density | 2 | 1.0 |
Gene Frequency | 17 | 0.0 |
Random Allocation | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Variation (Genetics)/*genetics | 2 | 0.0 |
*Variation (Genetics) | 4 | 0.0 |
Phosphorylation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Blood Proteins/*analysis | 5 | 3.0 |
Europe/ethnology | 2 | 2.0 |
Isoelectric Focusing | 10 | 1.0 |
*Polymorphism, Genetic | 12 | 0.0 |
Ethnic Groups/*genetics | 4 | 2.0 |
Variation (Genetics) | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Genotype | 2 | 0.0 |
Liver/metabolism | 2 | 0.0 |
Blood Proteins/analysis/*genetics | 2 | 50.0 |
*Genetics, Population | 5 | 1.0 |
Immunoblotting | 5 | 0.0 |
Isoelectric Focusing/methods | 2 | 6.0 |
Cell Line | 3 | 0.0 |
Isoelectric Focusing/*methods | 2 | 5.0 |
Germany | 2 | 0.0 |
Africa, Western | 2 | 9.0 |
Blood Proteins/genetics | 3 | 5.0 |
Europe | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Japan | 4 | 0.0 |
Pregnancy | 2 | 0.0 |
Asian Continental Ancestry Group/*genetics | 2 | 0.0 |
Genetic Markers | 6 | 0.0 |
Spain | 4 | 1.0 |
*Alleles | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
*Bone Density | 2 | 1.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Blood Group Antigens/*genetics | 2 | 1.0 |
Child | 3 | 0.0 |
Gene Frequency/genetics | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Complement Factor B/genetics | 2 | 2.0 |
Factor XIII/genetics | 2 | 25.0 |
Plasminogen/genetics | 2 | 33.0 |
Transferrin/genetics | 2 | 4.0 |
Vitamin D-Binding Protein/genetics | 2 | 7.0 |
alpha 1-Antitrypsin/genetics | 2 | 9.0 |
Jews/genetics | 2 | 2.0 |
DNA/genetics | 3 | 0.0 |
Bone Density/*genetics | 2 | 1.0 |
Ethnic Groups | 2 | 0.0 |
Fibronectins/*genetics | 3 | 10.0 |
Pedigree | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Genes, Structural | 4 | 0.0 |
Sex Factors | 2 | 0.0 |
